Strong order book masks revenue miss; execution critical

Q2 filed revenue ₹147.9 Cr; 27% lower than claimed

Q2 filed PAT ₹16.4 Cr; matches claim within rounding

Claimed EBITDA at ₹27 Cr from ₹16.7 Cr Q1; not independently verified

₹1,420 Cr unexecuted order book confirmed in call; strong visibility provided

Unexecuted order book grew to ₹1,420 Cr (2.8x FY26 revenue); single ₹600 Cr Maharashtra order in Q2 is largest in company history.

Q2 benefited from order commissioning and execution milestones (final invoices); management expects normalization to 14% EBITDA in steady state.

IPO proceeds will reduce debt (near-term trigger visible in Q3/Q4). Surety bonds replacing bank guarantees will lower future cost. Currently at BBB+ rating; upgrade to A expected.

Planning to enter 2–3 more states (unspecified names) for RDSS scheme; will bid around ₹1–1.5 Cr in new tenders with ~30% historical success rate.

₹950 Cr added in H1 (₹600 Cr Maharashtra in Q2 alone, 2-year execution). Bill-to-order historically 70–80%; execution in Q3–Q4 will be visible. WC to remain H1 weak, H2 strong due to government payment cycles.

Q2 benefited from revenue composition (order commissioning, execution milestones). Margin 'around 14%' going forward; will normalize as revenue composition stabilizes. 1–2% EBITDA margin expansion expected in future.

Distribution 85%, renewable 8%, transmission 6%. Margin stabilization expected as company scales; no quantified change guidance provided.

Two triggers: near-term (IPO proceeds support balance sheet, debt goes down in next 2–3 quarters); long-term (credit rating upgrade from BBB+ to A will reduce cost; surety bonds replacing bank guarantees). No quantified debt reduction timeline given.

Historically, bill-to-order ratio ~70–80%. No project delays in 15 years. Execution lag: distribution shorter, transmission/RoW issues longer. Ready status varies but 70% of order book executable within 6–12 months (qualitative, not quantified per order).

Contractually protected against price escalation; surety bonds mitigate some labor volatility. No specific cost inflation threshold given. Margin discipline 'maintained historically and will be maintained in future.'

Started with ₹50 lakh order, now bid ₹1,000 Cr+ orders. Only 4–5 players in India can bid ₹1,000 Cr single orders. Expected closure of ₹325 Cr in next months. 40% CAGR revenue growth (FY22–26: ₹59–504 Cr) shows execution capability.

Currently in 9 states (Haryana, Rajasthan, Gujarat, Himachal, Uttarakhand, Maharashtra, Goa, West Bengal, Assam). RDSS work in Rajasthan/Gujarat ongoing, recently awarded Maharashtra (ADB-funded). Planning 2–3 more states in Q3. DER/BESS sector 'promising' but not quantified; no timeline for entry.

Every tender bid includes price escalation clause in contract document. Lag is monthly basis. No ceiling limit; back-to-back protection from government depending on funding agency (World Bank, ADB, REC criteria allow 20–30% escalation).

Management only commits to 'maintain same growth rate' (historical 40% CAGR) but does not quantify FY27 revenue target. Vague and non-binding.

Current unexecuted ₹1,420 Cr; implies ₹80–580 Cr incremental inflows over 6 months. Consistent with ₹950 Cr H1 inflows run rate. Provides execution visibility.

New state expansions (2–3 states) and larger tender participation. Success rate of 30% is low; implies ₹300–450 Cr expected wins (directional, not binding).

Management states as range anchor, not floor. Delivered Q2 ~14.7% (₹27 Cr / ₹188 claimed = 14.4%, unverified). No guidance on quarterly variation due to seasonality.

Vague and non-binding ('expect growth of EBITDA by 1–2%'). Suggests modest upside, contradicts historical 77% EBITDA CAGR and bullish tone.

₹1,420 Cr order book = 2.8x FY26 revenue. Bill-to-order ratio 70–80% assumed; any slippage (project delays, client scope changes) impacts ₹500+ Cr H2 FY27 and FY28 revenue guidance.

14% EBITDA margin guidance is qualitative and assumes stable commodity costs and labor availability. Q1 FY27 experienced 'price volatility and supply uncertainty' forcing conservative working capital stance. Contractual escalation clauses (monthly lag, subject to funding agency caps) may not fully offset inflation.

No single-customer revenue disclosed, but 85% of order book is distribution (RDSS scheme), which is state-government-funded. ₹600 Cr Maharashtra order is single entity. Government budget delays, policy changes (RDSS phase-out), or fund allocation cuts could impact revenue.

Management claimed Q2 revenue ₹188 Cr (+42% QoQ) but filed result ₹147.9 Cr (27% lower). PAT claim ₹16 Cr matches filed ₹16.4 Cr. Discrepancy suggests either transcription error, internal reforecast, or gap in financial control. Erodes confidence in forward guidance.

H1 working capital is tight due to government payment delays (budget cycles); H2 releases are better. Receivables days are 'seasonally lower in H2' due to year-end government clearances, but margin for error is low if payment delays extend.